Novo Nordisk updates on DKK 15B share repurchase program

Novo Nordisk provided an update on its ongoing share repurchase program, which aims to repurchase up to DKK 15 billion over a 12-month period starting February 4, 2026. A specific program initiated on May 6, 2026, targets repurchasing B shares up to DKK 11,200,000,010.45 by February 1, 2027. As of June 19, 2026, the company has repurchased a total of 20,959,179 B shares for DKK 5,577,005,168 since February 4, 2026. Novo Nordisk now owns 38,144,480 B shares as treasury shares, representing 0.9% of its share capital.